Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Staar Surgical Company (STAA)
:STAA
Holding STAA?
Track your performance easily
Earnings Data
Report Date
Feb 19, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.04Last Year’s EPS
0.13Same Quarter Last Year
Based on 8 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 31, 2018
|% Change Since: -24.42%
|Next Earnings Date:Aug 01, 2018
Earnings Call Sentiment|Positive
STAAR Surgical demonstrated strong global sales growth, particularly in the U.S., EMEA, Japan, and South Korea, with strategic investments in training and infrastructure. However, challenges in China and a decrease in gross margins due to production issues were notable concerns. Overall, the company shows resilience and a positive growth trajectory.Company Guidance
During the third quarter of 2024 earnings call for STAAR Surgical, the company provided guidance highlighting several key metrics. STAAR achieved net sales of $88.6 million, marking a 10% increase year-over-year, driven by a 10% rise in ICL sales. Gross profit was reported at $68.5 million, representing 77.3% of net sales, although this was a decrease from 79.2% in the previous year due to reduced unit production. Operating expenses rose by 10% to $62.8 million compared to the prior year. Despite a challenging macroeconomic environment, particularly in China, STAAR maintained its fiscal year sales outlook, anticipating net sales between $340 million and $345 million. The company also reported a GAAP net income of $10 million or $0.20 per diluted share and adjusted EBITDA of $16.2 million or $0.33 per diluted share. The balance sheet remained strong with cash and equivalents at $236 million. STAAR's outlook reflects both positive regional performances, such as 14% sales growth in the Americas, and macroeconomic challenges in other regions, including China.Double-Digit Sales Growth
Net sales of $88.6 million were achieved with double-digit sales growth, despite a challenging macroeconomic environment, particularly in China. Fiscal year 2024 sales outlook maintained at $340 million to $345 million.
EVO ICL Experience Center Launch
The new EVO ICL Experience Center was launched at Lake Forest, Southern California, featuring advanced technology and workstations for 60 individuals, enhancing training and education programs.
U.S. Market Outperformance
U.S. sales grew 16% year-over-year, outpacing the market, which was down 18%. Three additional fast lane agreements were signed, with fast lane customers showing 61% ICL sales growth.
Strong EMEA Performance
EMEA region delivered 12% sales growth, driven by the Middle East and European distributor markets, outperforming initial expectations.
Japan and South Korea Growth
Japan sales grew by 15% with sustained double-digit unit growth. South Korea achieved 11% sales growth, supported by the country's first ICL-only clinic.
Improved Financial Position
GAAP net income increased to $10 million or $0.20 per diluted share, up from $4.8 million. Cash, cash equivalents, and investments rose to $236 million.
---
STAA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
STAA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 30, 2024 | $29.49 | $28.99 | -1.70% |
| Aug 07, 2024 | $36.35 | $40.36 | +11.03% |
| May 07, 2024 | $46.65 | $41.02 | -12.07% |
| Feb 26, 2024 | $31.75 | $32.68 | +2.93% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Staar Surgical Company (STAA) report earnings?
Staar Surgical Company (STAA) is schdueled to report earning on Feb 19, 2025, TBA Not Confirmed.
What is Staar Surgical Company (STAA) earnings time?
Staar Surgical Company (STAA) earnings time is at Feb 19, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is STAA EPS forecast?
STAA EPS forecast for the fiscal quarter 2024 (Q4) is -0.04.
---